Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Yakult Honsha Co ( (JP:2267) ) has shared an update.
Yakult Honsha Co., Ltd. has announced its Board of Directors’ unanimous decision to oppose all shareholder proposals put forth by DALTON KIZUNA (MASTER) FUND LP at the upcoming general meeting. The proposals include amendments to the Articles of Incorporation related to capital cost management and stock price awareness, share repurchase, and the structure of outside directors. Yakult’s Board argues that the company already meets the Tokyo Stock Exchange’s requirements for capital cost and profitability disclosures, and has introduced a new Medium-term Management Plan to enhance business growth and capital allocation.
The most recent analyst rating on (JP:2267) stock is a Hold with a Yen3300.00 price target. To see the full list of analyst forecasts on Yakult Honsha Co stock, see the JP:2267 Stock Forecast page.
More about Yakult Honsha Co
Yakult Honsha Co., Ltd. operates in the life sciences industry, focusing on the development and sale of probiotic products. The company is renowned for its research and expertise in microorganisms, aiming to enhance health and happiness globally through its offerings.
Average Trading Volume: 1,497,284
Technical Sentiment Signal: Sell
Current Market Cap: Yen966.7B
For a thorough assessment of 2267 stock, go to TipRanks’ Stock Analysis page.